Multimodal 4d Therapy Tender

Multimodal 4D -Therapy Of Pediatric High Grade Glioma

Paediatric high grade glioma (pHGG) is the most common malignant childhood brain tumour with standard-of-care inevitably resulting in therapy-resistant relapse or disease progression. The need for new combinatorial treatments is universally acknowledged; however, modern combination therapies are sparse, include at most two modalities and have so far not been able to significantly improve the dismal prognosis of the disease.

Funded Under
European Research Council (Erc)
Total Cost
€ 1 493 711,00
Eu Contribution
€ 1 493 711,00
Coordinated By
Deutsches Krebsforschungszentrum Heidelberg
Germany